Your browser doesn't support javascript.
loading
Female-specific risk factors for cardiovascular disease: an update.
Theodorou, Angeliki; Karagiannakis, Dimitrios S; Stefanaki, Katerina; Kassi, Evanthia; Peppa, Melpomeni; Vryonidou, Andromachi; Paschou, Stavroula A.
Affiliation
  • Theodorou A; Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, 80 Vasilisis Sophias Avenue, Athens, PC, 11528, Greece.
  • Karagiannakis DS; Academic Department of Gastroenterology, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Stefanaki K; Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, 80 Vasilisis Sophias Avenue, Athens, PC, 11528, Greece.
  • Kassi E; Endocrine Unit, First Department of Propaedeutic and Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Peppa M; Endocrine Unit and Diabetes Center, Second Department of Internal Medicine, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Vryonidou A; Department of Endocrinology and Diabetes Center, Hellenic Red Cross Hospital, Athens, Greece.
  • Paschou SA; Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, School of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, 80 Vasilisis Sophias Avenue, Athens, PC, 11528, Greece. s.a.paschou@gmail.com.
Hormones (Athens) ; 2024 Jun 26.
Article in En | MEDLINE | ID: mdl-38922384
ABSTRACT
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. While it was previously believed that men have greater susceptibility to CVD, recent research suggests that women face an increased risk of CVD after the onset of menopause, primarily due to the loss of the protective effects of estrogens. Premature ovarian insufficiency (POI), polycystic ovarian syndrome (PCOS), and gestational factors, such as gestational diabetes mellitus (GDM), recurrent pregnancy loss, preterm delivery, and preeclampsia, are specific reproductive disorders that may contribute to an elevated risk of CVD at earlier ages, i.e., before the onset of menopause. This suggests that women with these conditions should be closely monitored for CVD risk factors even before reaching menopause. Such early intervention may help reduce the incidence of CVD and improve overall cardiovascular health in this population. The precise pathophysiological mechanism underlying the development of CVD in women with menopause, premature POI, PCOS, and gestational factors remains elusive. This review article seeks to elucidate the latest research on the relationship between these conditions and CVD in women, aiming to explore the underlying pathogenic mechanisms contributing to this association.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hormones (Athens) Journal subject: ENDOCRINOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hormones (Athens) Journal subject: ENDOCRINOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: